Literature DB >> 19067664

Impact of tips preliver transplantation for the outcome posttransplantation.

G P Guerrini1, M Pleguezuelo, S Maimone, V Calvaruso, E Xirouchakis, D Patch, N Rolando, B Davidson, K Rolles, A Burroughs.   

Abstract

The effects of transjugular intrahepatic portocaval shunt (TIPS) on the survival of grafts and patients after liver transplantation (LTx) have only been documented in small series and with only a comparative description with non-TIPS recipients. We evaluated 61 TIPS patients who had a subsequent LTx and compared these with 591 patients transplanted with cirrhosis without TIPS. Pretransplant characteristics were similar between groups. Graft survival at 1, 3 and 5 years post-LTx was 85.2%, 77% and 72.1% (TIPS) and 75.3%, 69.8% and 66.1% (controls). Patient survival at the same points was 91.7%, 85% and 81.7%, respectively (TIPS) and 85.4%, 80.3% and 76.2% (controls). Cox regression showed the absence of TIPS pre-LTx, transfusion of >5 units of blood during LTx, intensive care unit (ICU) stay post-LTx >3 days and earlier period of transplant to be significantly associated with a worse patient and graft survival at 1 year. Migration of the TIPS stent occurred in 28% of cases, increasing the time on bypass during LTx, but was not related to graft or patient survival. TIPS may improve portal supply to the graft and reduce collateral flow, improving function. This may account for the improved adjusted graft and patient survival by Cox regression at 12 months. Long-term survival was not affected.

Entities:  

Mesh:

Year:  2008        PMID: 19067664     DOI: 10.1111/j.1600-6143.2008.02472.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  10 in total

Review 1.  The management of patients awaiting liver transplantation.

Authors:  Ka-Kit Li; James Neuberger
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-10-06       Impact factor: 46.802

2.  Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study.

Authors:  Pusen Wang; Ying Pu; Hao Li; Baojie Shi; Shengnai Zheng; Lin Zhong
Journal:  Springerplus       Date:  2016-10-18

3.  Impact of transjugular intrahepatic porto-systemic shunt on post liver transplantation outcomes: Study based on the United Network for Organ Sharing database.

Authors:  Khalid Mumtaz; Sherif Metwally; Rohan M Modi; Nishi Patel; Dmitry Tumin; Anthony J Michaels; James Hanje; Ashraf El-Hinnawi; Don Hayes; Sylvester M Black
Journal:  World J Hepatol       Date:  2017-01-18

4.  Portal vein thrombosis in patients with cirrhosis.

Authors:  Leona von Köckritz; Andrea De Gottardi; Jonel Trebicka; Michael Praktiknjo
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-24

Review 5.  Salvage versus Primary Liver Transplantation for Hepatocellular Carcinoma: A Twenty-Year Experience Meta-Analysis.

Authors:  Gian Piero Guerrini; Giuseppe Esposito; Tiziana Olivieri; Paolo Magistri; Roberto Ballarin; Stefano Di Sandro; Fabrizio Di Benedetto
Journal:  Cancers (Basel)       Date:  2022-07-16       Impact factor: 6.575

6.  The transjugular intrahepatic portosystemic shunt in the treatment of portal hypertension: current status.

Authors:  Gilles Pomier-Layrargues; Louis Bouchard; Michel Lafortune; Julien Bissonnette; Dave Guérette; Pierre Perreault
Journal:  Int J Hepatol       Date:  2012-07-19

Review 7.  Therapy Algorithm for Portal Vein Thrombosis in Liver Cirrhosis: The Internist's Point of View.

Authors:  Martin Rössle; Birke Bausch; Christoph Klinger
Journal:  Viszeralmedizin       Date:  2014-12

Review 8.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03

Review 9.  Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate.

Authors:  Mariella Faccia; Maria Elena Ainora; Francesca Romana Ponziani; Laura Riccardi; Matteo Garcovich; Antonio Gasbarrini; Maurizio Pompili; Maria Assunta Zocco
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

Review 10.  Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.

Authors:  Riccardo Inchingolo; Alessandro Posa; Martin Mariappan; Tiago Kojun Tibana; Thiago Franchi Nunes; Stavros Spiliopoulos; Elias Brountzos
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.